Blasts 10 Percent or More of Peripheral Blood White Cells
1 clinical trials · Condition
◉ Watch Blasts 10 Percent or More of Peripheral Blood White Cells
| Record | Firm | Date |
|---|---|---|
| Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia (NCT02115295) | M.D. Anderson Cancer Center | 2014-05-19 |
Track Blasts 10 Percent or More of Peripheral Blood White Cells automatically
Every clearance here is in the API, with alerts when new ones post.